Symbols

RKDA

Arcadia Biosciences·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 1

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About RKDA

Arcadia Biosciences, Inc.

A provider of agricultural products and technology solutions focused on improving crop yields and sustainability

Industry

Food

Established Date

Listing Date

05/15/2015

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.arcadiabio.com

Security Type

Common stock

Office address

5956 Sherry Lane Suite 2000 Dallas TX 75225

Business

Introduction

Arcadia Biosciences, Inc. was founded in Arizona in 2002 and reorganized in Delaware in March 2015. The company leverages its history as a leader in science-based approaches to develop high-value products and drive innovation in the consumer goods industry. Since acquiring Zola's assets in May 2021, the company has provided consumers with a way to hydrate, reset and rejuvenate with Zola coconut water products. Previously, the company mainly developed wheat products and commercialized them through the sale of food products, trait licensing and royalty agreements.

Company Financials

EPS

RKDA has released its 2025 Q4 earnings. EPS was reported at -0.97, versus the expected -0.66, missing expectations. The chart below visualizes how RKDA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

RKDA has released its 2025 Q4 earnings report, with revenue of 901.00K, reflecting a YoY change of -25.90%, and net profit of -1.34M, showing a YoY change of 67.13%. The Sankey diagram below clearly presents RKDA's revenue sources and cost distribution.